Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
11/17/2010 | CN101886068A Immobilized SUMO system and immobilized SUMO removal system |
11/17/2010 | CN101885778A HPV (Human Papilloma Virus) 16 type L2N120E7E6 fusion protein, gene, preparation method and application |
11/17/2010 | CN101885758A Auto-antigen epitope and encoding gene and application thereof |
11/17/2010 | CN101884783A Wheat bran polypeptide-containing anti-fatigue traditional Chinese medicine and preparation method thereof |
11/17/2010 | CN101884782A Application of bifidobacterium longum adherence inhibition protein Aip for preventing and treating diarrhea |
11/17/2010 | CN101565714B Carbon resource-dependent genetic transformation system for trichoderma reesei and use thereof |
11/16/2010 | US7834258 Dimer of chimeric recombinant binding domain-functional group fusion formed via disulfide-bond-bridge and the processes for producing the same |
11/16/2010 | US7834237 Membrane-localisable fusion protein of an aggregating portion induced through conformational polymerisation |
11/16/2010 | US7834166 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
11/16/2010 | US7834161 Process for proteolytic cleavage and purification of recombinant proteins produced in plants |
11/16/2010 | US7834159 Pharmacokinetics; glycosyltransferases; vaccines |
11/16/2010 | US7834156 Monoclonal antibody comprising cytotoxic fusion for use in treatment of cell proliferative disorers |
11/16/2010 | US7834155 using the conjugates in the inhibition of cell growth; cancer; monoclonal antibody or epitope-binding fragment thereof, that recognizes and binds the CA6 glycotope |
11/16/2010 | US7834154 Angiogenesis inhibition |
11/16/2010 | US7833988 Oncoprotein specific immunoglobulin for use as tool in tumor diagnosis and treatment; antitumor agents |
11/16/2010 | US7833786 Anti-IL-6 antibodies, compositions, methods and uses |
11/16/2010 | US7833773 Bacillus mHKcel cellulase |
11/16/2010 | US7833771 Polypeptides having alpha-amylase activity and polynucleotides encoding same |
11/16/2010 | US7833769 McrA variants and uses thereof |
11/16/2010 | US7833768 Polypeptides having phytase activity |
11/16/2010 | US7833759 Method of increasing complementarity in a heteroduplex |
11/16/2010 | US7833754 nucleic acids improved for the expression of interleukin-12 (IL-12); improved cytokine expression in mammalian cells by optimizing all steps of gene expression of the cytokine |
11/16/2010 | US7833753 Mixture comprising sialinated erythropoietin (EPO) for use in generating stable, human, recombinant proteins that are modified post-translationally |
11/16/2010 | US7833752 Expression vector comprising nucleotoide sequences coding signal sequences which direct proteins to periplasmic compartment; improving exogenous expression of heterologous polypeptides |
11/16/2010 | US7833749 used as a reporter gene for cellular systems in combination with bioluminescent or chemoluminescent systems; for energy transfer systems |
11/16/2010 | US7833728 Soluble form of carbonic anhydrase IX (s-CA IX), assays to detect s-CA IX, CA IX's coexpression with HER-2/neu/c-erbB-2, and CA IX-specific monoclonal antibodies to non-immunodominant epitopes |
11/16/2010 | US7833717 Using neisserial surface protein nucleotide sequences as tool in detection, prevention and treatment of microorganismal infection; immunodiagnostics; immunotherapeutics; vaccine development |
11/16/2010 | US7833529 secreted tumor necrosis factor receptor polypeptides; modulates B cell activation; inhibiting transmembrane activator and CAML-interactor (TACI)//BCMA ; autoimmune disease; inflammation |
11/16/2010 | US7833528 Drug delivery where chemotherapeutic drug is converted to an active drug by a target-tissue-localized complex that comprises an enzyme formed by premixing bispecific monoclonal antibody or bispecific antibody fragment with a hapten-enzyme covalent conjugate |
11/16/2010 | US7833521 Admnistering a fusion protein of interferon and albumin or an albumin variant, having a higher plasma stability than unfused interferon; albumin or variant is located either at the N-terminus or C-terminus of the fusion protein, fusion protein retains the therapeutic activity of unfused interferon |
11/16/2010 | US7833520 Cytokine receptor protein for use in identifying modulators which prevent hepatitis viral replication and infection; viricides |
11/16/2010 | US7832626 Anonymous competition entry |
11/16/2010 | CA2523216C Recombinant alphavirus vectors |
11/16/2010 | CA2436846C Thioether substituted imidazoquinolines |
11/16/2010 | CA2422622C Novel baff-r nucleic acids and polypeptides |
11/16/2010 | CA2352073C F0f1-atpase and dna encoding the same |
11/16/2010 | CA2311648C Ifnar2/ifn complex |
11/16/2010 | CA2283462C Vectors having enhanced expression and methods of making and uses thereof |
11/16/2010 | CA2278151C Heregulin variants |
11/16/2010 | CA2197804C Method for the production of recombinant proteins, plasmids and modified cells |
11/15/2010 | CA2704505A1 Method and system for protein purification |
11/11/2010 | WO2010129917A2 Anti-cd100 antibodies and methods for using the same |
11/11/2010 | WO2010129724A2 Efficient biomass fractionating system for an energy pulse crop |
11/11/2010 | WO2010129469A1 Stable high protein concentration formulations of human anti-tnf-alpha-antibodies |
11/11/2010 | WO2010129304A2 Method for making heteromultimeric molecules |
11/11/2010 | WO2010128657A1 Novel monoclonal antibody for analyzing high-molecular weight adiponectin and utilization of same |
11/11/2010 | WO2010128084A1 Probiotic microorganisms isolated from donkey milk |
11/11/2010 | WO2010127492A1 Recombinant bcg vaccine rbcg::xb |
11/11/2010 | WO2010127444A1 Increasing protein production b\ increasing abc50 expression or activity |
11/11/2010 | WO2010075541A3 System for production of ethanol and co-products |
11/11/2010 | WO2007133835A8 Ras mutation and compositions and methods related thereto |
11/11/2010 | US20100287670 Protein expression system |
11/11/2010 | US20100287637 Methods of blocking tissue destruction by autoreactive t cells |
11/11/2010 | US20100287632 Rapid Production of Monoclonal Antibodies |
11/11/2010 | US20100287630 Models for vaccine assessment |
11/11/2010 | US20100287629 Transgenic Non-Human Animals For Producing Chimeric Antibodies |
11/11/2010 | US20100286381 Diagnostic method for cancer characterized in the detection of the deletion of g-csf exon 3 |
11/11/2010 | US20100286375 Carrier molecules |
11/11/2010 | US20100286374 Method for making antibody fc-heterodimeric molecules using electrostatic steering effects |
11/11/2010 | US20100286371 Methods of Activating Clostridial Toxins |
11/11/2010 | US20100286367 Conjugates of soluble peptidic compounds with membrane-binding agents |
11/11/2010 | US20100286366 Polypeptide libraries with a predetermined scaffold |
11/11/2010 | US20100286364 Glycosylated glycopeptide antibiotic derivatives |
11/11/2010 | US20100286068 Molecular markers of plant embryogenesis |
11/11/2010 | US20100286067 Glycoconjugation of polypeptides using oligosaccharyltransferases |
11/11/2010 | US20100286034 Uses for aqueous streams containing proteins |
11/11/2010 | US20100285988 Gamma-Secretase Substrates And Methods Of Use |
11/11/2010 | US20100285563 Non-Ribosomal Peptide Synthetases |
11/11/2010 | US20100285533 Culture media additive and process for using it |
11/11/2010 | US20100285532 Production of heterologous proteins or peptides |
11/11/2010 | US20100285531 Therapeutic and Diagnostic Methods and Compositions Targeting 4Ig-B7-H3 and its Counterpart NK Cell Receptor |
11/11/2010 | US20100285530 E.Coli Host Cells with Modified Phos/Psts Periplasmic Phosphate-binding Proteins, and Method of Manufacturing Recombinant Fabs |
11/11/2010 | US20100285529 Feline granulocyte macrophage colony stimulating factor proteins |
11/11/2010 | US20100285528 Method, vector and system for expressing polypeptides |
11/11/2010 | US20100285527 Novel Polypeptide, cDNA Encoding the Same, and Use Thereof |
11/11/2010 | US20100285526 Compositions and Methods for Fusion Protein Separation |
11/11/2010 | US20100285525 Method |
11/11/2010 | US20100285502 Novel aromatic prenyltransferases, nucleic acids encoding same and uses therefor |
11/11/2010 | US20100285449 Human G-Protein Chemokine Receptor (CCR5) HDGNR10 |
11/11/2010 | US20100285132 Immunotherapy compositions, method of making and method of use thereof |
11/11/2010 | US20100285104 Compositions and methods for the delivery of oxygen |
11/11/2010 | US20100285070 Polynucleotides of haemophilus parasuis and its use |
11/11/2010 | US20100285048 Use of flagellin in the immunotherapy of yersinia pestis |
11/11/2010 | US20100285036 Anti-CD100 Neutralizing Antibodies and Methods of Using the Same |
11/11/2010 | US20100285027 Antibodies specific for human hepcidin |
11/11/2010 | US20100285017 Matriptase protein and uses thereof |
11/11/2010 | US20100285014 Immunoglobulin fusion proteins |
11/11/2010 | US20100285009 Humanized anti-egfl7 antibodies and methods using same |
11/11/2010 | US20100284971 Modified factor viii and factor ix genes and vectors for gene therapy |
11/11/2010 | US20100284920 Uses of monoclonal antibody 8h9 |
11/11/2010 | US20100284916 Antibodies Against Human Cytomegalovirus (HCMV) |
11/11/2010 | CA2761435A1 Increasing protein production by increasing abc50 expression or activity |
11/11/2010 | CA2761141A1 Probiotic microorganisms isolated from donkey milk |
11/11/2010 | CA2760980A1 Novel monoclonal antibody for analyzing high-molecular weight adiponectin and utilization of same |
11/11/2010 | CA2760890A1 Anti-cd100 antibodies and methods for using the same |
11/10/2010 | EP2248908A1 Probiotic microorganisms isolated from donkey milk |
11/10/2010 | EP2248901A1 Streptogramines and method for preparing same by mutasynthesis |
11/10/2010 | EP2248892A2 Fusion constructs and use of same to produce antibodies with increased FC receptor binding affinity and effector function |
11/10/2010 | EP2248831A1 Glycosylated antibodies |
11/10/2010 | EP2248826A1 Antibody directed against pcrv |